The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT).
 
Deaglan Joseph McHugh
Consulting or Advisory Role - Progenics
 
Maria Clara Fernandes
No Relationships to Disclose
 
Samuel Aaron Funt
Employment - ByHeart (I)
Stock and Other Ownership Interests - Allogene Therapeutics; Doximity; IconOVir Bio; Kite, a Gilead company; Kronos Bio; Neogene Therapeutics; Urogen pharma; Vida Ventures
Consulting or Advisory Role - Immunai; Merck
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Maria Bromberg
No Relationships to Disclose
 
Andrea Knezevic
Consulting or Advisory Role - ByHeart
 
Ines Nikolovski
No Relationships to Disclose
 
Darren R. Feldman
Consulting or Advisory Role - Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Seagen
Other Relationship - UpToDate